ZEMPLAR 2 ug/1ml sol inj 2 µg 5 pce

7680563120020 CH-56312 H05BX02 07.05.0.

Active substances:

ZEMPLAR 2 ug/1ml sol inj 2 µg 5 pce
ZEMPLAR 2 ug/1ml sol inj 2 µg 5 pce
ZEMPLAR 2 ug/1ml sol inj 2 µg 5 pce
1 / 3
google

Details

Product number
5631203
CPT
-
Packaging group
5
Unit
Durchstechflasche(n)
Composition
paricalcitolum 2 µg, ethanolum 170 mg, propylenglycolum 310 mg, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

Zemplar 2 ug/1ml, Injektionslösung
Injektionslösung
5
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
13/11/2024
Professional SmPC
Français
13/11/2024
Professional SmPC
Italien
13/11/2024

Detailed composition

Substance Quantity Type Category
paricalcitolum
2.0 UG Substance Wirkstoff (Principe actif)
ethanolum
170.0 MG Substance HNIDK
propylenglycolum
310.0 MG Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 67.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2016

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
56312
Drug name
Zemplar, Injektionslösung
Galenic form
LSPA
ATC Code
H05BX02
Authorization status
Z
Dispensation category
B
First authorization
09/08/2004
Authorization expiration date
31/12/9999
IT number
07.05.0.
Domain
Human medicine
Field of application
Behandlung des sekundären Hyperparathyreoidismus

Packaging details

Description (FR)
ZEMPLAR 2 ug/1ml sol inj 2 µg 5 pce
Description (DE)
ZEMPLAR 2 ug/1ml Inj Lös 2 µg 5 Stk
Market launch
06/11/2007
Narcotic (BTM)
No

Other packaging sizes

ZEMPLAR 5 ug/1ml sol inj 5 µg 5 pce
5 DUR
View
ZEMPLAR 10 ug/2ml sol inj 10 µg 5 pce
5 DUR
View
Buy us a coffee Explore the data